Late Sodium Current And I<sub>f</sub> Inhibition: Targets of New Antianginal Drugs

Authors

  • Uzzwal Kanti Das Medicine, General Hospital, Noakhali
  • Syed Ali Ahsan Interventional Cardiology, UCC, BSMMU, Dhaka
  • KMHS Sirajul Haque Department of Cardiology, UCC, BSMMU, Dhaka
  • Md. Khurshed Ahmed Cardiology, Ucc, BSMMU, Dhaka

DOI:

https://doi.org/10.3329/uhj.v3i2.796

Keywords:

Late Sodium current (IPNa), Diastolic tension, After depolarization, If, current, heart rate

Abstract

Ischaemic heart disease is the common cause of mortality and morbidity in developed countries despite tremendous development in treatment in last two decades. Recently cardiac Ion Channels and other cellular components have become the target of research for new cardiovascular drugs. A number of new drugs have emerged after pre-clinical and clinical trials. Ranolazine by inhibiting late sodium current in ventricular cardiomyocytes and ibavradine by inhibiting If current in pacemaker cells have emerged as effective new antianginal drugs. Both are discussed in this review article. Key Words: Late Sodium current (IPNa), Diastolic tension, After depolarization, If current, heart rate. (University Heart Journal 2007; 3 : 75-78)

Downloads

Download data is not yet available.
Abstract
761
PDF
569

Downloads

How to Cite

Das, U. K., Ahsan, S. A., Haque, K. S., & Ahmed, M. K. (2008). Late Sodium Current And I<sub>f</sub> Inhibition: Targets of New Antianginal Drugs. University Heart Journal, 3(2), 75–78. https://doi.org/10.3329/uhj.v3i2.796

Issue

Section

Review Articles